Hu Sheng-Shou
The Writing Committee of the Report on Cardiovascular Health and Diseases in China.
J Geriatr Cardiol. 2024 Oct 28;21(10):931-943. doi: 10.26599/1671-5411.2024.10.008.
The Annual Report on Cardiovascular Health and Diseases in China (2022) intricate landscape of car-diovascular health in China. In connection with the previous section, this 10 section of the report offers a comprehensive analysis of aortic disease and peripheral artery disease. Aortic dissection is a critical disease, with a higher incidence in men than in women. The main risk factors include hypertension, gene mutations, and so on. Recent studies suggest that young patients with aortic dissection have a higher body mass index, and there is a significant correlation between low ambient temperature and sudden temperature drop and the onset of dissection. The main hazards are aortic rupture or poor branch perfusion, which is life threatening. According to the lesion location, it is divided into Stanford A type (involving the ascending aorta) and Stanford B type (not involving the ascending aorta). The treatment of type A dissection is mainly open surgery, while the treatment of type B dissection is preferably endovascular treatment. In recent years, with the continuous development of endovascular technique, the treatment of aortic arch lesions has transformed gradually from open to hybrid, and then to total endovascular treatment. The prevalence of abdominal aortic aneurysm is relatively low (< 1%), and its risk factors mainly include smoking, hypertension, dyslipidemia, etc. The main hazard is the rupture of the aneurysm leading to death. Currently, treatment methods include endovascular repair and open surgery. According to data from Hospital Quality Monitoring System (HQMS), in the past five years, the number of open and endovascular operations for aortic disease in China has shown an upward trend, which may be due to the popularization of diagnostic and therapeutic techniques and increased attention to aortic disease. The in-hospital mortality rates of thoracic endovascular aortic repair, endovascular aortic repair, and Bentall operations are relatively low (all < 2%). Due to the complexity and difficulty of the operation, the in-hospital mortality of total arch replacement is 5.9%-7.4%. Overall, the in-hospital mortality decreased while the number of surgeries increased. This section also elaborates on the five peripheral artery diseases (PADs): lower extremity artery disease (LEAD), carotid atherosclerotic disease, subclavian artery stenosis, mesenteric artery disease and renal artery stenosis, from the perspectives of epidemiology, risk factors, evaluation methods, diagnosis, and treatment. PAD is common among middle-aged and elderly people, and is significantly related to the risk factors of cardiovascular disease. Diagnosis and treatment methods are constantly being improved and updated. Besides traditional evaluation methods, artificial intelligence, molecular biology and other methods have been continuously developed, improving diagnostic sensitivity and specificity. Treatment methods include risk factor control, medication, revascularization (percutaneous endovascular intervention and surgical treatment), and exercise etc. New treatment methods such as cell engineering and xenogeneic vascular graft have also shown promise in the treatment of LEAD.
《中国心血管健康与疾病报告(2022)》展示了中国心血管健康的复杂图景。与上一节相关联,本报告的这一部分对主动脉疾病和外周动脉疾病进行了全面分析。主动脉夹层是一种危急疾病,男性发病率高于女性。主要危险因素包括高血压、基因突变等。近期研究表明,主动脉夹层年轻患者的体重指数较高,且环境低温和气温骤降与夹层发病之间存在显著相关性。主要危害是主动脉破裂或分支灌注不良,危及生命。根据病变部位,可分为斯坦福A型(累及升主动脉)和斯坦福B型(不累及升主动脉)。A型夹层的治疗主要是开放手术,而B型夹层的治疗首选血管腔内治疗。近年来,随着血管腔内技术的不断发展,主动脉弓病变的治疗已逐渐从开放手术转变为杂交手术,进而发展为完全血管腔内治疗。腹主动脉瘤的患病率相对较低(<1%),其危险因素主要包括吸烟、高血压、血脂异常等。主要危害是动脉瘤破裂导致死亡。目前,治疗方法包括血管腔内修复和开放手术。根据医院质量监测系统(HQMS)的数据,在过去五年中,中国主动脉疾病的开放手术和血管腔内手术数量呈上升趋势,这可能归因于诊断和治疗技术的普及以及对主动脉疾病的关注度提高。胸主动脉腔内修复术、主动脉腔内修复术和Bentall手术的院内死亡率相对较低(均<2%)。由于手术的复杂性和难度,全弓置换术的院内死亡率为5.9%-7.4%。总体而言,手术数量增加的同时,院内死亡率下降。本节还从流行病学、危险因素、评估方法、诊断和治疗等方面阐述了五种外周动脉疾病(PADs):下肢动脉疾病(LEAD)、颈动脉粥样硬化疾病、锁骨下动脉狭窄、肠系膜动脉疾病和肾动脉狭窄。外周动脉疾病在中老年人中较为常见,且与心血管疾病的危险因素显著相关。诊断和治疗方法不断改进和更新。除了传统评估方法外,人工智能、分子生物学等方法也不断发展,提高了诊断的敏感性和特异性。治疗方法包括危险因素控制、药物治疗、血运重建(经皮血管腔内介入治疗和手术治疗)以及运动等。细胞工程和异种血管移植物等新治疗方法在下肢动脉疾病的治疗中也显示出前景。